By Dennis Ford, Founder & CEO, LSN
This Thanksgiving, we’d like to say thank you for all our Next Phase readers, LSN platform subscribers, RESI attendees and all our friends in the life science investment and entrepreneurship communities. We’re grateful for your support, and we hope to support your success in turn during the year to come.
As is LSN’s Thanksgiving tradition, we’re serving up the 10 most recent life science investment mandates gathered by LSN Research. These mandates show the breadth of coverage that LSN has among life science investors, with investors including international PE firms, expert regional VCs, disease-focused nonprofits, cross-border funds, and family offices. If one of these investors is a fit for your opportunity, we’d love to hear from you.
Click on the mandates below to see what’s cooking in the rest of the world
- Cross-Border VC Seeks PMA & 510k Medical Devices
- Family Office Medtech Fund Interested in Dental, Aesthetics and Mobile Tech
- VC Invests in Technology Platforms in Medtech & Lab Equipment
- Southwest VC Invests in Diagnostics, HCIT, Devices & Enabling Technologies
- VC Invests in Medtech & HCIT Hospital Solutions in NoCal
- Foundation Invests in Cancer Cures Worldwide
- Asia VC Invests in Pharmaceuticals & Medtech in the USA
- PE Firm Seeks Healthcare Opportunities in India
- VC Invests in HCIT, Medical Devices and Diagnostics in Europe
- Merchant Bank Seeks Strategic Medtech Opportunities for China Expansion
Leave a Reply